Treatment of advanced head/neck squamous cell carcinoma in elderly patients with weekly intravenous bleomycin

被引：0
|
作者：
Gebbia, V
Fallica, G
Borsellino, N
Testa, A
Varvara, F
Mauceri, G
机构：
[1] Ctr Catanese Oncol, Div Med Oncol & Radiotherapy, Catania, Italy
[2] Clin Noto, Serv Oncol, Palermo, Italy
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
102
引用
收藏
页码：72 / 73
页数：2
相关论文
共 50 条
  • [31] Bleomycin, epirubicin, carboplatin (BECA) in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Adamo, V
    Maisano, R
    Pergolizzi, S
    Altavilla, G
    Caristi, N
    Chiofalo, G
    Scimone, A
    Settineri, N
    JOURNAL OF CHEMOTHERAPY, 1997, 9 (01) : 72 - 76
  • [32] Prognosis classifier for elderly head-and-neck squamous cell carcinoma patients
    Ruehle, A.
    Stromberger, C.
    Haehl, E.
    Senger, C.
    Falkenstein, A. E.
    Stoian, R.
    Zamboglou, C.
    Knopf, A.
    Grosu, A.
    Nicolay, N.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S843 - S843
  • [33] Toxicity of Cetuximab in Locally Advanced Head and Neck Squamous Cell Carcinoma Treatment
    Torres, S.
    Sargento, I.
    Ferreira, M.
    Oliveira, J. O. A. O.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S552 - S552
  • [34] Head and Neck Squamous Cell Carcinoma in Elderly Patients: Role of Radiotherapy and Chemotherapy
    Fasano, Morena
    D'Onofrio, Ida
    Belfiore, Maria Paola
    Angrisani, Antonio
    Caliendo, Valentina
    Della Corte, Carminia Maria
    Pirozzi, Mario
    Facchini, Sergio
    Caterino, Marianna
    Guida, Cesare
    Nardone, Valerio
    Reginelli, Alfonso
    Cappabianca, Salvatore
    CANCERS, 2022, 14 (03)
  • [35] Elderly Patients With Squamous Cell Carcinoma of the Head and Neck and the Benefit of Multimodality Therapy
    Moye, Virginia A.
    Chandramouleeswaran, Sindhu
    Zhao, Ni
    Muss, Hyman B.
    Weissler, Bmark C.
    Hayes, David N.
    Zevallos, Jose P.
    ONCOLOGIST, 2015, 20 (02): : 159 - 165
  • [36] Immunological Treatment Options for Locoregionally Advanced Head and Neck Squamous Cell Carcinoma
    Schutt, Christopher
    Bumm, Klaus
    Mirandola, Leonardo
    Bernardini, Giovanni
    D' Cunha, Nicholas
    Tijani, Lukman
    Diane Nguyen
    Cordero, Joehassin
    Jenkins, Marjorie R.
    Cobos, Everardo
    Kast, W. Martin
    Chiriva-Internati, Maurizio
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2012, 31 (01) : 22 - 42
  • [37] 3-weekly or weekly cisplatin concurrently with radiotherapy for patients with locally advanced squamous cell carcinoma of the head and neck - A multicentre, retrospective analysis
    Rothschild, S., I
    Helfenstein, S.
    Riesterer, O.
    Meier, U. R.
    Papachristofilou, A.
    Kasenda, B.
    Pless, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 248 - 248
  • [38] 3-weekly or weekly cisplatin concurrently with radiotherapy for patients with locally advanced squamous cell carcinoma of the head and neck: A multicentre, retrospective analysis
    Rothschild, S. I.
    Helfenstein, S.
    Riesterer, O.
    Meier, U. R.
    Papachristofilou, A.
    Kasenda, B.
    Pless, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [39] TREATMENT OF LOCALLY ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK WITH CONCURRENT BLEOMYCIN AND EXTERNAL BEAM RADIATION-THERAPY
    SEAGREN, SL
    BYFIELD, JE
    NAHUM, AM
    BONE, RC
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1979, 5 (09): : 1531 - 1535
  • [40] Hypofractionated radiotherapy combined with cetuximab in vulnerable elderly patients with locally advanced head and neck squamous cell carcinoma
    Francesca De Felice
    Luigia Vetrone
    Nadia Bulzonetti
    Rossella Caiazzo
    Francesco Marampon
    Daniela Musio
    Vincenzo Tombolini
    Medical Oncology, 2019, 36
12345